811 related articles for article (PubMed ID: 34314914)
21. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, antimicrobial, anti-cancer and in silico studies of new urea derivatives.
Sroor FM; Othman AM; Tantawy MA; Mahrous KF; El-Naggar ME
Bioorg Chem; 2021 Jul; 112():104953. PubMed ID: 33964581
[TBL] [Abstract][Full Text] [Related]
23. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
24. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors.
El-Adl K; El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Nasser M; Abulkhair HS; El-Hddad SSA
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000279. PubMed ID: 33073374
[TBL] [Abstract][Full Text] [Related]
26. Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity.
Abdel-Rahman AA; Shaban AKF; Nassar IF; El-Kady DS; Ismail NSM; Mahmoud SF; Awad HM; El-Sayed WA
Molecules; 2021 Jun; 26(13):. PubMed ID: 34206976
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and Antimicrobial, Anticancer and Anti-Oxidant Activities of Novel 2,3-Dihydropyrido[2,3-d]pyrimidine-4-one and Pyrrolo[2,1-b][1,3]benzothiazole Derivatives via Microwave-Assisted Synthesis.
Al-Mutairi AA; Hafez HN; El-Gazzar ABA; Mohamed MYA
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209034
[TBL] [Abstract][Full Text] [Related]
28. Antiproliferative evaluations of triazoloquinazolines as classical DNA intercalators: Design, synthesis, ADMET profile, and molecular docking.
Eissa IH; Ibrahim MK; Alesawy MS; El-Adl K
Arch Pharm (Weinheim); 2022 May; 355(5):e2100487. PubMed ID: 35194810
[TBL] [Abstract][Full Text] [Related]
29. Novel Pyrazolo[3,4-b]pyridine Derivatives: Synthesis, Characterization, Antimicrobial and Antiproliferative Profile.
Salem MS; Ali MA
Biol Pharm Bull; 2016; 39(4):473-83. PubMed ID: 27040621
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, In Vitro Antimicrobial and Cytotoxic Activities of Some New Pyrazolo[1,5-
Fouda AM; Abbas HS; Ahmed EH; Shati AA; Alfaifi MY; Elbehairi SEI
Molecules; 2019 Mar; 24(6):. PubMed ID: 30893820
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, molecular docking of new lipophilic acetamide derivatives affording potential anticancer and antimicrobial agents.
Ahmed HEA; Ihmaid SK; Omar AM; Shehata AM; Rateb HS; Zayed MF; Ahmed S; Elaasser MM
Bioorg Chem; 2018 Feb; 76():332-342. PubMed ID: 29227917
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.
Mohamed MF; Mohamed MS; Shouman SA; Fathi MM; Abdelhamid IA
Appl Biochem Biotechnol; 2012 Nov; 168(5):1153-62. PubMed ID: 22948604
[TBL] [Abstract][Full Text] [Related]
33. Benzoxazole/benzothiazole-derived VEGFR-2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations.
El-Helby AA; Sakr H; Eissa IH; Al-Karmalawy AA; El-Adl K
Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900178. PubMed ID: 31596514
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, antimicrobial and anti-cancer activities of some new N-ethyl, N-benzyl and N-benzoyl-3-indolyl heterocycles.
El-Sawy ER; Mandour AH; Mahmoud K; Islam IE; Abo-Salem HM
Acta Pharm; 2012 Jun; 62(2):157-79. PubMed ID: 22750815
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, anticancer, and docking of some S- and/or N-heterocyclic derivatives as VEGFR-2 inhibitors.
El-Adl K; Abdel-Rahman AA; Omar AM; Alswah M; Saleh NM
Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100237. PubMed ID: 34862655
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
El-Sayed Ali T
Eur J Med Chem; 2009 Nov; 44(11):4385-92. PubMed ID: 19586688
[TBL] [Abstract][Full Text] [Related]
37. DNA interaction, antimicrobial, anticancer activities and molecular docking study of some new VO(II), Cr(III), Mn(II) and Ni(II) mononuclear chelates encompassing quaridentate imine ligand.
Abdel-Rahman LH; Abu-Dief AM; Aboelez MO; Hassan Abdel-Mawgoud AA
J Photochem Photobiol B; 2017 May; 170():271-285. PubMed ID: 28456118
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives.
Fargualy AM; Habib NS; Ismail KA; Hassan AM; Sarg MT
Eur J Med Chem; 2013 Aug; 66():276-95. PubMed ID: 23811090
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors.
El-Adl K; Ibrahim MK; Khedr F; Abulkhair HS; Eissa IH
Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100278. PubMed ID: 34596910
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of novel thiazolo[4,5-d]pyrimidine derivatives for antimicrobial, anti-HIV and anticancer investigation.
Rida SM; Habib NS; Badawey EA; Fahmy HT; Ghozlan HA
Pharmazie; 1996 Dec; 51(12):927-31. PubMed ID: 8985982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]